PHE - Corporate - Foetal Anomaly Screening
Use of quadruple testing to detect trisomy 18 and alpha-fetoprotein as an adjunct to ultrasound to detect spina bifida and anencephaly in the second trimester
Buyer
Public Health England
Value
£39,248
Published
26 Mar 2020
Closes
23 Mar 2020
Procurement details
Source
Contracts Finder
Region
United Kingdom
Procurement method
Other Competition From Framework
Category
Services
Contract starts
29 Mar 2020
Contract ends
30 Apr 2021
CPV classifications
75122000
Administrative healthcare services
Lots
Lot default PHE - Corporate - Foetal Anomaly Screening
£39,248
Use of quadruple testing to detect trisomy 18 and alpha-fetoprotein as an adjunct to ultrasound to detect spina bifida and anencephaly in the second trimester
Delivery: British Oversea Territories, Channel Islands, Europe, Isle of Man, Rest of the World, United Kingdom
Documents
Unlock document linkAwarded contract notice on Contracts Finder
26 Mar 2020
Awarded contract notice on Contracts Finder
Award notice · Web page
Contains public sector information licensed under the Open Government Licence v3.0.